Dr. Geoffrey Ling is the CEO of On Demand Pharmaceuticals, which is developing manufacturing technology for point-of- care end-to-end generic pharmaceutical production. He is a pharmacologist, neuro-intensive care physician and Professor at Johns Hopkins Hospital, former founding Director of the Biological Technologies Office at DARPA and former Assistant Director for Medical Innovation in President Obama’s Office of Science, Technology and Policy (OSTP). Dr. Ling is a retired U.S. Army colonel physician who served in both Iraq and Afghanistan. More information about Dr. Ling can be found at: https://en.wikipedia.org/wiki/Geoffrey_Ling
An investment of $5 billion over five years will improve U.S. pharmaceutical manufacturing infrastructure.
The federal government can directly address the massive market failures at the center of our healthcare enterprise by establishing a new Health Advanced Research Projects Agency.